Search Results - "Rosenthal, E.L."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2
  3. 3

    Wound healing following combined radiation and cetuximab therapy in head and neck cancer patients by Dean, N.R, Sweeny, L, Harari, P.M, Bonner, J.A, Jones, V, Clemons, L, Geye, H, Rosenthal, E.L

    Published in Journal of wound care (01-04-2011)
    “…objective: This study set out to determine if cetuximab treatment increases the risk of wound healing complications when combined with radiation therapy…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors by Rosenthal, E.L., Chung, T.K., Parker, W.B., Allan, P.W., Clemons, L., Lowman, D., Hong, J., Hunt, F.R., Richman, J., Conry, R.M., Mannion, K., Carroll, W.R., Nabell, L., Sorscher, E.J.

    Published in Annals of oncology (01-07-2015)
    “…The use of Escherichia coli purine nucleoside phosphorylase (PNP) to activate fludarabine has demonstrated safety and antitumor activity during preclinical…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation by McNally, L R, Rosenthal, E L, Zhang, W, Buchsbaum, D J

    Published in Cancer gene therapy (01-03-2009)
    “…Recent studies have demonstrated the efficacy of targeted therapy combined with radiotherapy in head and neck squamous cell carcinoma (HNSCC). We hypothesized…”
    Get full text
    Journal Article